Annual Cash & Cash Equivalents
$14.47 M
+$256.00 K+1.80%
December 31, 2023
Summary
- As of March 6, 2025, ABEO annual cash & cash equivalents is $14.47 million, with the most recent change of +$256.00 thousand (+1.80%) on December 31, 2023.
- During the last 3 years, ABEO annual cash & cash equivalents has risen by +$1.88 million (+14.90%).
- ABEO annual cash & cash equivalents is now -89.49% below its all-time high of $137.75 million, reached on December 31, 2017.
Performance
ABEO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.73 M
-$18.70 M-54.32%
September 30, 2024
Summary
- As of March 6, 2025, ABEO quarterly cash and cash equivalents is $15.73 million, with the most recent change of -$18.70 million (-54.32%) on September 30, 2024.
- Over the past year, ABEO quarterly cash and cash equivalents has stayed the same.
- ABEO quarterly cash and cash equivalents is now -88.58% below its all-time high of $137.75 million, reached on December 31, 2017.
Performance
ABEO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABEO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | 0.0% |
| 3 y3 years | +14.9% | -64.1% |
| 5 y5 years | -22.8% | -67.2% |
ABEO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.1% | +1.8% | -54.3% | +236.0% |
| 5 y | 5-year | -88.8% | +14.9% | -87.8% | +236.0% |
| alltime | all time | -89.5% | +4047.0% | -88.6% | >+9999.0% |
Abeona Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.73 M(-54.3%) |
| Jun 2024 | - | $34.43 M(+96.1%) |
| Mar 2024 | - | $17.56 M(+21.3%) |
| Dec 2023 | $14.47 M(+1.8%) | $14.47 M(+207.2%) |
| Sep 2023 | - | $4.71 M(-24.3%) |
| Jun 2023 | - | $6.22 M(+33.0%) |
| Mar 2023 | - | $4.68 M(-67.1%) |
| Dec 2022 | $14.22 M(-56.8%) | $14.22 M(+148.0%) |
| Sep 2022 | - | $5.73 M(-6.5%) |
| Jun 2022 | - | $6.13 M(-69.8%) |
| Mar 2022 | - | $20.33 M(-38.3%) |
| Dec 2021 | $32.94 M(+161.5%) | $32.94 M(-24.8%) |
| Sep 2021 | - | $43.78 M(+61.1%) |
| Jun 2021 | - | $27.18 M(+90.5%) |
| Mar 2021 | - | $14.27 M(+13.3%) |
| Dec 2020 | $12.60 M(-90.3%) | $12.60 M(+49.5%) |
| Sep 2020 | - | $8.42 M(-42.1%) |
| Jun 2020 | - | $14.54 M(-63.8%) |
| Mar 2020 | - | $40.16 M(-68.9%) |
| Dec 2019 | $129.26 M(+589.4%) | $129.26 M(+169.7%) |
| Sep 2019 | - | $47.92 M(+12.5%) |
| Jun 2019 | - | $42.61 M(+64.4%) |
| Mar 2019 | - | $25.92 M(+38.3%) |
| Dec 2018 | $18.75 M(-86.4%) | $18.75 M(-44.2%) |
| Sep 2018 | - | $33.60 M(-32.8%) |
| Jun 2018 | - | $49.99 M(-62.1%) |
| Mar 2018 | - | $132.00 M(-4.2%) |
| Dec 2017 | $137.75 M(+99.2%) | $137.75 M(+143.7%) |
| Sep 2017 | - | $56.52 M(-3.1%) |
| Jun 2017 | - | $58.30 M(-7.8%) |
| Mar 2017 | - | $63.21 M(-8.6%) |
| Dec 2016 | $69.14 M(+72.3%) | $69.14 M(+121.7%) |
| Sep 2016 | - | $31.18 M(-9.1%) |
| Jun 2016 | - | $34.30 M(-8.3%) |
| Mar 2016 | - | $37.40 M(-6.8%) |
| Dec 2015 | $40.14 M(+248.4%) | $40.14 M(-7.3%) |
| Sep 2015 | - | $43.28 M(+42.3%) |
| Jun 2015 | - | $30.41 M(+282.6%) |
| Mar 2015 | - | $7.95 M(-31.0%) |
| Dec 2014 | $11.52 M(+2617.0%) | $11.52 M(+6881.8%) |
| Sep 2014 | - | $165.00 K(+200.0%) |
| Jun 2014 | - | $55.00 K(-81.6%) |
| Mar 2014 | - | $299.00 K(-29.5%) |
| Dec 2013 | $424.00 K(+7.1%) | $424.00 K(-52.8%) |
| Sep 2013 | - | $899.00 K(-50.0%) |
| Jun 2013 | - | $1.80 M(+3496.0%) |
| Mar 2013 | - | $50.00 K(-87.4%) |
| Dec 2012 | $396.00 K(-83.9%) | $396.00 K(+273.6%) |
| Sep 2012 | - | $106.00 K(-82.0%) |
| Jun 2012 | - | $588.00 K(-56.9%) |
| Mar 2012 | - | $1.36 M(-44.5%) |
| Dec 2011 | $2.46 M | $2.46 M(+82.5%) |
| Sep 2011 | - | $1.35 M(-69.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $4.35 M(-29.6%) |
| Mar 2011 | - | $6.17 M(-12.2%) |
| Dec 2010 | $7.03 M(+1058.6%) | $7.03 M(+370.1%) |
| Sep 2010 | - | $1.50 M(-45.8%) |
| Jun 2010 | - | $2.76 M(-35.5%) |
| Mar 2010 | - | $4.28 M(+604.8%) |
| Dec 2009 | $607.00 K(-77.3%) | $607.00 K(-63.7%) |
| Sep 2009 | - | $1.67 M(+35.8%) |
| Jun 2009 | - | $1.23 M(-44.2%) |
| Mar 2009 | - | $2.21 M(-17.6%) |
| Dec 2008 | $2.68 M(-61.3%) | $2.68 M(+1231.8%) |
| Sep 2008 | - | $201.00 K(+109.4%) |
| Jun 2008 | - | $96.00 K(-57.5%) |
| Mar 2008 | - | $226.00 K(-96.7%) |
| Dec 2007 | $6.92 M(+479.6%) | $6.92 M(+947.0%) |
| Sep 2007 | - | $661.00 K(+288.8%) |
| Jun 2007 | - | $170.00 K(-52.6%) |
| Mar 2007 | - | $359.00 K(-69.9%) |
| Dec 2006 | $1.19 M(+242.1%) | $1.19 M(+147.7%) |
| Sep 2006 | - | $482.00 K(-66.3%) |
| Jun 2006 | - | $1.43 M(-58.7%) |
| Mar 2006 | - | $3.46 M(+892.3%) |
| Dec 2005 | $349.00 K(-80.3%) | $349.00 K(-7.7%) |
| Sep 2005 | - | $378.00 K(-51.8%) |
| Jun 2005 | - | $784.00 K(-72.9%) |
| Mar 2005 | - | $2.89 M(+62.7%) |
| Dec 2004 | $1.77 M(+144.2%) | $1.77 M(-60.5%) |
| Sep 2004 | - | $4.49 M(-27.0%) |
| Jun 2004 | - | $6.15 M(-26.4%) |
| Mar 2004 | - | $8.36 M(+1049.4%) |
| Dec 2003 | $727.00 K(-49.7%) | $727.00 K(+63.0%) |
| Sep 2003 | - | $446.00 K(-86.4%) |
| Jun 2003 | - | $3.29 M(+2.1%) |
| Mar 2003 | - | $3.22 M(+123.2%) |
| Dec 2002 | $1.44 M(-80.6%) | $1.44 M(-21.7%) |
| Sep 2002 | - | $1.84 M(-67.1%) |
| Jun 2002 | - | $5.61 M(-55.7%) |
| Mar 2002 | - | $12.67 M(+70.7%) |
| Dec 2001 | $7.43 M(-11.8%) | $7.43 M(-14.9%) |
| Sep 2001 | - | $8.72 M(+55.4%) |
| Jun 2001 | - | $5.62 M(+15.3%) |
| Mar 2001 | - | $4.87 M(-42.1%) |
| Dec 2000 | $8.41 M(+835.0%) | $8.41 M(+17.4%) |
| Sep 2000 | - | $7.17 M(+617.3%) |
| Jun 2000 | - | $999.00 K(-70.8%) |
| Mar 2000 | - | $3.42 M(+279.9%) |
| Dec 1999 | $900.00 K(-40.0%) | $900.00 K(-55.6%) |
| Sep 1999 | - | $2.03 M(+685.3%) |
| Jun 1999 | - | $258.00 K(-70.9%) |
| Mar 1999 | - | $887.00 K |
| Dec 1998 | $1.50 M(+242.5%) | - |
| Dec 1997 | $438.00 K(-90.1%) | - |
| Dec 1996 | $4.43 M(+134.5%) | - |
| Dec 1995 | $1.89 M | - |
FAQ
- What is Abeona Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Abeona Therapeutics?
- What is Abeona Therapeutics annual cash & cash equivalents year-on-year change?
- What is Abeona Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Abeona Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ABEO is $14.47 M
What is the all time high annual cash & cash equivalents for Abeona Therapeutics?
Abeona Therapeutics all-time high annual cash & cash equivalents is $137.75 M
What is Abeona Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ABEO annual cash & cash equivalents has changed by +$256.00 K (+1.80%)
What is Abeona Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ABEO is $15.73 M
What is the all time high quarterly cash and cash equivalents for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly cash and cash equivalents is $137.75 M
What is Abeona Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ABEO quarterly cash and cash equivalents has changed by $0.00 (0.00%)